| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.125 | - | - | - | - | 8.247 | 13.101 | 13.716 | 11.806 | 8.644 |
| Total Income - EUR | 4.125 | - | - | - | - | 8.247 | 13.101 | 13.716 | 11.806 | 8.644 |
| Total Expenses - EUR | 525 | - | - | - | - | 8.750 | 12.050 | 12.312 | 12.116 | 12.123 |
| Gross Profit/Loss - EUR | 3.600 | - | - | - | - | -503 | 1.052 | 1.403 | -309 | -3.478 |
| Net Profit/Loss - EUR | 3.476 | - | - | - | - | -584 | 867 | 1.266 | -410 | -3.737 |
| Employees | 0 | - | - | - | - | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Vgr Intensiv Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29 | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.559 | - | - | - | - | 2.560 | 3.740 | 4.903 | 3.913 | 542 |
| Inventories | 360 | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | - | - | - | - | 413 | 819 | 213 | 943 | 285 |
| Cash | 3.199 | - | - | - | - | 2.147 | 2.922 | 4.690 | 2.970 | 257 |
| Shareholders Funds | 3.521 | - | - | - | - | 598 | 1.452 | 2.722 | 2.304 | -1.446 |
| Social Capital | 45 | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 67 | - | - | - | - | 1.962 | 2.289 | 2.181 | 1.609 | 1.988 |
| Income in Advance | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vgr Intensiv Med Srl